https://www.thebodypro.com/category/prep-hiv-pre-exposure-prophylasxis/tag/african-americans

The Latest

This Week in HIV Research: Fentanyl Smooths the Path for HIV

April 4, 2019: what’s driving the HIV outbreak in northeastern Massachusetts; race-gender HIV disparities among Baltimore sex workers; high PrEP interest, low awareness among southern black women; naltrexone implants for opioid dependence.

Black Gay and Bisexual Men Demonstrate High PrEP Adherence in Hotly Anticipated Study Img

Black Gay and Bisexual Men Demonstrate High PrEP Adherence in Hotly Anticipated Study

This study shows that with the right supportive services, black men who have sex with men will use pre-exposure prophylaxis (PrEP), and with very high adherence.

PrEP Use Doesn't Increase STIs Among Black MSM, New Study Shows Img

PrEP Use Doesn't Increase STIs Among Black MSM, New Study Shows

Some have expressed concern that, as PrEP use increases in the U.S., so will the transmission of other STIs. A new study pushes back against that worry.

This Week in HIV Research: Rethinking PrEP Guidelines

Alternate PrEP guideline recommendations; partner notification and onward HIV transmission; shifting causes of death among HIV/HCV-coinfected people; correlates of lower adherence among people on methadone maintenance.

This Week in HIV Research: A Long-Acting Popularity Contest

The most popular form of long-acting HIV treatment; telehealth for PrEP uptake among young MSM of color; PrEP awareness and usage among Rhode Island women; assessing cognitive benefits of switching off of efavirenz.

This Week in HIV Research: Transgender Women in the Spotlight

Black transgender women and the HIV care continuum; PrEP uptake potential among trans women; an update on U.S. mother-to-child HIV transmission; is extra measles vaccination necessary?

This Week in HIV Research: Many Black MSM on PrEP Are Already Positive

High HIV prevalence among black MSM on PrEP; substance use reduction lessens depressive symptoms; correlations between pain symptoms and age; the impact of seroconversion and antiretroviral therapy on risk behaviors.

This Week in HIV Research: The PrEP Sex/Race Gap

PrEP access appears far from equal in the U.S.; HIV treatment and viral suppression disparities in Europe; how today’s hepatitis C treatments affect mortality; sex-based differences in cognitive impairment.

This Week in HIV Research: The Case for Pre-Pregnancy Treatment

The benefits of pre-pregnancy HIV treatment initiation for mothers-to-be; HIV diagnoses rise among young U.S. MSM; cost effectiveness of PrEP for heterosexual women; methotrexate and arterial function.

This Week in HIV Research: Vitamin D for CD4? Eh.

The effect of vitamin D levels on CD4 count during HIV treatment; helping black men who have sex with men utilize PrEP; HIV and aortic stiffness; Legionnaires’ disease severity among people with HIV.